Evidence map›Paper›PMID 31780780›Full record

ReviewNature reviews. Endocrinology2020

The effects of growth hormone on adipose tissue: old observations, new mechanisms.

John J Kopchick, Darlene E Berryman, Vishwajeet Puri, Kevin Y Lee, Jens O L Jorgensen

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nature reviews. Endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07333521 (Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.), which is not on this map. Cited by 113 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 2 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07333521 recruitingnot on this mapstarted 2026, after this paper: background citation

Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2026 to 2034Enrolled200ConditionsIsolated Non-acquired Growth Hormone DeficiencyArmsAuxological measurements and impedancemetry
3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 2 syntheses or guidelines pooled it, 172 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Effects ofInternational journal of environmental research and public health · 2022
    Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. The theory of the inflammatory ecosystem.Science China. Life sciences · 2026
    Review
  10. Article
  11. Article
  12. [Multiple clinical effects of recombinant human growth hormone therapy].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  13. Review
  14. What is the future of acromegaly therapy?The Journal of clinical endocrinology and metabolism · 2026
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

John J KopchickEdison Biotechnology Institute, Ohio University, Athens, OH, USA. kopchick@ohio.edu.ORCID http://orcid.org/0000-0003-4561-2177
Darlene E BerrymanEdison Biotechnology Institute, Ohio University, Athens, OH, USA.
Vishwajeet PuriThe Diabetes Institute, Ohio University Heritage College of Osteopathic Medicine, Athens, OH, USA.
Kevin Y LeeThe Diabetes Institute, Ohio University Heritage College of Osteopathic Medicine, Athens, OH, USA.
Jens O L JorgensenDepartment of Endocrinology and Diabetes, Aarhus University Hospital, Aarhus, Denmark.
Biotechnology Institute · USOhio University · USAarhus University Hospital · DK

Funding

Modulating Growth Hormone Action as a Target for Improved Health and LongevityR01AG059779 · NIA · OHIO UNIVERSITY ATHENS · PI John Joseph Kopchick · 2018 to 2026
$4.7M
Identifying a novel regulatory pathway of vascular function in obesityR01HL140836 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GOKCE, NOYAN, PURI, VISHWAJEET · 2018 to 2021
$2.2M
Cide Proteins and Regulation of Energy ExpenditureR01DK101711 · NIDDK · OHIO UNIVERSITY ATHENS · PI PURI, VISHWAJEET · 2014 to 2016
$1.1M
NHLBI NIH HHS R01 HL140836NIA NIH HHS R01 AG059779NIDDK NIH HHS R01 DK101711
6 · The paper itself

Abstract

The ability of growth hormone (GH) to induce adipose tissue lipolysis has been known for over five decades; however, the molecular mechanisms that mediate this effect and the ability of GH to inhibit insulin-stimulated glucose uptake have scarcely been documented. In this same time frame, our understanding of adipose tissue has evolved to reveal a complex structure with distinct types of adipocyte, depot-specific differences, a biologically significant extracellular matrix and important endocrine properties mediated by adipokines. All these aforementioned features, in turn, can influence lipolysis. In this Review, we provide a historical and current overview of the lipolytic effect of GH in humans, mice and cultured cells. More globally, we explain lipolysis in terms of GH-induced intracellular signalling and its effect on obesity, insulin resistance and lipotoxicity. In this regard, findings that define molecular mechanisms by which GH induces lipolysis are described. Finally, data are presented for the differential effect of GH on specific adipose tissue depots and on distinct classes of metabolically active adipocytes. Together, these cellular, animal and human studies reveal novel cellular phenotypes and molecular pathways regulating the metabolic effects of GH on adipose tissue.

Indexed as

Adipose TissueAnimalsGrowth HormoneHumansMutationThyroid HormonesGrowth HormoneThyroid Hormones

Identifiers

PMID31780780
PMCPMC7180987
OpenAlexW2990706223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.